![]() |
DETECTABUSE™ "NO VACUUM" GRAVITY SERIES GV-65 METHOD FOR THE ANALYSIS OF HYDROLYZED OR "FREE" OPIATES IN URINE BY GC-MS |
Although this method has performed well in our laboratory, it must be validated by your laboratory before it is used to report patient values. We would appreciate your comments on its performance and welcome your suggestions for improvements or enhancements. |
Revised: January 2003 (* TEA Elution Solvent Stability) |
|
SAMPLE PREPARATION- (Please see Notes and Supplemental Information before proceeding)
A. Acid Hydrolysis 4. Cap tubes and heat in autoclave or heating block. (See note C at the end of the sample prep. section) 5. Cool tubes. 6. Add 1.0 mL of a 12% aqueous Potassium Hydroxide (KOH) per mL of sample and mix. 12 g KOH (Assay 87%) is added to a 100 mL flask which is then carefully filled with Deionized Water. ( See precaution at the end of this section) 7. Add 1.0 mL of a 20% solution of monobasic Potassium Phosphate solution to each sample and mix (20 grams/100 mL H2O prepared monthly). Final pH should be between 2.5 and 3.5. If necessary, adjust the pH with a few drops of either 1N KOH or 1N HCl. 8. Samples should be centrifuged for 3 min. at 3000 RPM. Precaution: Adsorption must be done at an acidic pH of approximately 2.5-3.5. The 1.0 mL of KOH and buffer added in steps 6 and 7 ordinarily sets up the optimum pH for adsorption. If however, the pH is too high, i.e. greater than 4.0, drug recoveries will decline with increasing pH. If the pH is too low, the column washes will not remove all of the hydrolysis acid remaining on the column. The excess acid may cause the basic elution solvent to become weakly basic or acidic which will lead to partial or complete hindrance of drug elution. A non-bleeding pH paper can be used to test the pH of the eluate by wetting the paper with the solvent followed by a water rinse which will enable the color reaction to take place. This should only have to be done for the first run to assure that pH conditions are correct throughout the run. If you encounter any problems with this procedure please contact us for assistance.
B. Enzymatic Hydrolysis Sample Preparation Without Hydrolysis - "Measurement of Free Opiates"
(See Note D at the end of the sample prep. section)
1. Pipet 1.0 ml urine sample into a 16x100 mm pressure rated glass tube
with a Teflon® lined screw cap. Notes:
HARDWARE SETUP - (Please refer
to the Detectabuse Hardware Setup Instructions)
Column Conditioning and Activation of Cation Function
1. Wash column with 1.0 mL of Methanol. Allow to flow by gravity. SAMPLE EXTRACTION - (Please see Notes at end of this section
before proceeding)
1. Pour samples onto preconditioned column. Hydrolyzed samples should
be carefully poured to prevent transfer of hydrolysis debris onto the
column. Allow to flow by gravity. Samples will flow through the column
at a rate of 1-2 mL/min. Note: If liquids do not elute freely by gravity flow, there
is probably air trapped within the column bed or frits. Tapping the column
mounting plate onto the vacuum box should initiate flow.
SAMPLE ELUTION
1. Sample elution is done outside of the vacuum box. DERIVATIZATION - Following are some of the more commonly used
derivatizing schemes. Others such as PFPA are available upon request.
Single TMS DERIVATIZATION - Using BSTFA or MSTFA with 1% TMCS
Single DERIVATIZATION - Using MBTFA 1. To each dried extract add
50 µL Acetonitrile and 50µL N-Methyl-bis(trifluoroacetamide) (MBTFA).
Double Derivative - Oxime/TMS Note: Polar solvents commonly used for derivatization such as Acetonitrile or Ethyl Acetate will pick up moisture over time. Because moisture will inhibit or prevent derivatization it is important to keep a supply of solvents used for this purpose stored as protected from moisture as possible. Storing these solvents in a desiccator or flushing with Nitrogen or Argon after use is recommended. The use of the optional oxime derivative converts Morphone and Codone 6-Keto positions to their corresponding oximes which prevents direct silane formation via enolization at this site. The subsequent treatment of extracts with BSTFA or MSTFA forms the TMS derivative of Codeine and Morphine hydroxyl function and TMS/Oxime derivatives at the Keto-Oxime functions of the Codones and Morphones. This double derivative technique produces significantly different spectra and retention times for the Codones and Morphones without affecting Codeine and Morphine. The improved chromatographic separation produced by this technique results in complete separation of 6-Hydroxyl Opiates from 6-Keto Opiates on a 12 meter DB-1 or DB-5 column. Many laboratories use the MBTFA derivative without the oxime step. Although several compounds overlap, separation is achieved by ion selection. SUPPLEMENT - When using an automated robotic system, all liquids
may be allowed to flow unassisted through the column or may be pulled
through the column with vacuum or pushed through with positive pressure.
|
GC/MS ANALYSIS |
| GC/MS: Hewlett-Packard equipped with Mass Selective Detector |
| GC Column: H.P. Ultra 2 Capillary Column (or equivalent), 15 m x 0.25 mm, 0.25 µm film |
| Acquisition Mode: SIM
|
| Temperature Program -TMS |
| Injector Temp.: 260°C |
| Detector Temp.: 300°C |
| Initial: 140°C, program at 20°C/min. to 260°C Program from 260°C-275°C at 5°C/min. Program from 275°C-280°C at 25°C/min. |
| Equil. Time: 1.0 min. |
| Split Ratio: Splitless |
| He Flow: 1.0 mL/min. @ 200°C |
| Septum Purge: 2 mL/min. |
| Purge Off Time: 1.0 min. |
| Dwell: 30 |
| Solvent Delay: 3.5 min. |
| Start Acq.:3.5 min. |
| Stop Run: 9.0 min. |
| Temperature Program-MBTFA |
| Injector Temp.: 270°C |
| Detector Temp.: 290°C |
| Initial: 130°C,
Hold for 0.5 mins Program to 280°C at 30°C/min. Hold for 2 mins. |
| Equil. Time: 1.0 min. |
| Split Ratio: Splitless |
| He Flow: 1.0 mL/min. @ 200°C |
| Septum Purge: 2 mL/min. |
| Purge Off Time: 1.0 min. |
| Dwell: 30 |
| Solvent Delay: 3.5 min. |
| Start Acq.:3.5 min. |
| Stop Run: 8.0 min. |
|
MSD SIM PROGRAM
- TMS
|
||
| Drug | Ions Monitored (in order of abundance) |
Retention Time |
| Codeine-TMS | 343, 371, 372 | 6.75 min. |
| Codeine-D3-TMS | 346, 374 | 6.72 min. |
| Morphine-TMS | 236, 414, 429 | 7.08 min. |
| Morphine-D3-TMS | 417, 432 | 7.05 min. |
|
MSD SIM PROGRAM
- MBTFA
|
||
| Drug | Ions Monitored (in order of abundance) |
Retention Time |
| Morphine-d3 | 367, 480 | 4.83 min. |
| Morphine | 364, 477, 311 | 4.85 min. |
| Codeine-d3 | 285, 398 | 5.00 min. |
| Codeine | 282, 395, 283 | 5.02 min. |
| Retention time
and ion spectra will vary somewhat from instrument to instrument. ![]() GO TO: GV-65 Ordering Information |
||